Rivaroxaban (RIV) is one of the direct oral anticoagulants used to prevent and treat venous
and arterial thromboembolic events. Considering the therapeutic indications, RIV is likely to …

Purpose Rosuvastatin calcium (ROSCa) is a poorly soluble drug with bioavailability not
exceeding 20%. Decreasing the particle size may enhance its solubility, dissolution rate and …

Clopidogrel bisulfate (CB) is a golden antiplatelet treatment, yet its benefits are limited by its
low bioavailability (< 50%) caused by poor intestinal solubility and absorption. The present …

The aim of this study was to design a chitosan-coated hollow tin dioxide nanosphere (CS-
HSn) for loading febuxostat (FEB) using an adsorption method to obtain a sustained-release …

A validated stability indicating thin layer chromatographic (TLC) and liquid chromatography
coupled with mass spectrometry LC/MS methods were developed to analyse Rivaroxaban …

The present study evaluates the physical stability and intermolecular interactions of
Rivaroxaban (RXB) amorphous solid dispersions (ASDs) in polymeric carriers via …

Achieving the desired solubility and dissolution of active pharmaceutical ingredients (APIs)
continues to be a big challenge in the pharmaceutical industry. In this regard …

In this paper, two new Rivaroxaban crystalline forms are reported and characterized by the
single‐crystal X‐ray diffraction (SXRD), powder X‐ray diffraction (PXRD), thermogravimetric …

Poor bioavailability by the oral route is noticeable with the majority of new active
pharmaceutical ingredients due to its dissolution rate limited absorption. A second …

The current aim of this study is to develop a simple, sensitive, and robust analytical method
that can separate the Rivaroxaban and its related impurities by using HPLC. This new …